<DOC>
	<DOCNO>NCT00837928</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy , bendamustine , work different way stop growth tumor cell , either kill cell stop dividing . Stereotactic radiation therapy may able send x-ray directly tumor cause less damage normal tissue . PURPOSE : This phase I trial study side effect best dose bendamustine give together radiation therapy treat patient brain metastasis cause solid tumor .</brief_summary>
	<brief_title>Bendamustine Radiation Therapy Treating Patients With Brain Metastases Caused Solid Tumors</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine recommend phase II dose bendamustine hydrochloride administer combination stereotactic radiotherapy treatment patient 1-4 brain metastasis solid malignancy . Secondary - Determine bendamustine hydrochloride pharmacokinetics correlate bendamustine hydrochloride level brain metastasis , brain margin , arachnoid , cerebral spinal fluid , plasma acquire time surgery . - Assessment local control brain metastasis . OUTLINE : This dose-escalation study bendamustine hydrochloride . Patients potentially resectable lesion ( ) receive bendamustine hydrochloride IV 30 minute stereotactic radiotherapy daily 5 day . Patients potentially resectable lesion ( ) receive bendamustine hydrochloride IV 30 minute day 1-3 undergo surgery day 3 . At least 4 week surgery , patient receive adjuvant bendamustine hydrochloride stereotactic fractionate radiotherapy ( patient potentially resectable lesion [ ] ) Blood sample collect periodically pharmacokinetic study . Cerebrospinal fluid , arachnoid , tumor margin , tumor sample also collect surgery correlative study . After completion study treatment , patient follow every 3 month 21 month .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Bendamustine Hydrochloride</mesh_term>
	<criteria>Histologically confirm cancer 1 4 brain metastasis image MRI/CT scan involve thalamus , basal ganglion brain stem . No cancer originate central nervous system Candidate clinically indicate surgery resect brain lesion . Karnofsky score least 60 At least 18 year age Life expectancy two month Evidence leptomeningeal metastasis . Need immediate treatment prevent neurological deterioration . Prior brain radiotherapy surgery current brain metastasis . Radiosensitive primary tumor small cell lung cancer , germ cell tumor , lymphoma , leukemia multiple myeloma . Absolute neutrophil count ( ANC ) &lt; 1500/mm3 platelet &lt; 50,000/mms . Brain metastasis diameter great 5 cm . Not pregnant nursing More 3 week since prior chemotherapy . No evidence ischemia EKG and/or reduce cardiac ejection fraction ( i.e. , &lt; 50 % ) ECHO . No known sensitivity allergy bendamustine hydrochloride mannitol No 3 prior cytotoxic chemotherapy regimens No unresolved persistent toxicity 4 week prior chemotherapy 6 week nitrosoureas . Calculated creatinine clearance &lt; 40 ml/min .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>tumor metastatic brain</keyword>
</DOC>